Abvc Biopharma (ABVC) Restructuring Costs (2010 - 2012)
Abvc Biopharma's (ABVC) quarterly Restructuring Costs came in at $110305.0 in Q2 2012, down 80.96% YoY from $579320.0 in Q3 2011, and down 47.49% on a QoQ basis from $210080.0 in Q1 2012.
Abvc Biopharma (ABVC) Restructuring Costs (2010 - 2012) Analysis & Trends
Abvc Biopharma (ABVC) has 3 years of Restructuring Costs data on file, last reported at $110305.0 in Q2 2012.
- Quarterly Restructuring Costs fell 80.96% year-over-year to $110305.0 in Q2 2012, while the trailing twelve-month figure through Jun 2012 was $760188.0 (down 24.74% YoY) and the FY2011 annual result came in at $1.1 million, up 20.18% from the prior year.
- Restructuring Costs retreated to $110305.0 in Q2 2012, from $210080.0 in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $579320.0 in Q2 2011 to a low of $83743.0 in Q1 2011.
- A 3-year average of $212820.1 and a median of $209027.0 in 2011 frame the typical range for Restructuring Costs.
- Annual changes were most pronounced in 2011 — Restructuring Costs surged 299.3% — and 2012, when it slumped 80.96%.
- Tracing ABVC's Restructuring Costs over 3 years: stood at $211073.0 in 2010, then declined by 0.97% to $209027.0 in 2011, then slumped by 47.23% to $110305.0 in 2012.
- The last three Restructuring Costs figures came in at $110305.0 (Q2 2012), $210080.0 (Q1 2012), and $209027.0 (Q4 2011), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Abvc Biopharma | 23.34 Mn | 23.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2012 | 110,305.00 |
| Mar 31, 2012 | 210,080.00 |
| Dec 31, 2011 | 209,027.00 |
| Sep 30, 2011 | 230,776.00 |
| Jun 30, 2011 | 579,320.00 |
| Mar 31, 2011 | 83,743.00 |
| Dec 31, 2010 | 211,073.00 |
| Sep 30, 2010 | 135,972.00 |
| Jun 30, 2010 | 145,085.00 |